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ABSTRACT
A META-ANALYSIS OF COMPONENT TREATMENT STUDIES:
ARE THE PARTS AS GOOD AS THE WHOLE?
by Erin Jane Clarke
December 2011
Psychotherapy has been proven effective in treating a variety of mental health
issues. However, there is disagreement in psychotherapy research about whether or not
factors common to all psychotherapies or specific ingredients within a treatment package
are responsible for successful treatment outcomes. Component studies are research
designs specifically aimed at identifying the mechanisms of change in a full treatment
package. Component studies do this by comparing the differences in outcome among
dismantled treatment components and the full treatment protocol. The present metaanalytic review of component studies examined whether or not differences between these
two treatment groups generally exist. Fifty-nine component studies were analyzed to
determine the difference in the outcome between dismantled treatments and full treatment
packages. Studies were coded on a number of variables including sample size,
intervention type, treatment problem, gender, and age. As hypothesized, results from 59
comparisons of post-treatment score differences revealed that there are not differences
between the full treatment package and the component treatment (d = -.005). These
results mirrored the findings from Ahn and Wampold’s (2001) original meta-analysis of
20 component studies. However, there was significant heterogeneity among these studies,
with treatment effectiveness moderated by age (i.e., older clients benefiting more from
ii

the full treatment packages; β = -.316). The present study also examined treatment
outcomes at follow-up. The follow-up results from 44 comparisons of component groups
and full treatment package groups indicated that the full treatment package was more
effective than the component group (d = -.157). The results from this study suggest that
specific ingredients in psychotherapy packages do have an effect, but these effects may
not be apparent at post treatment, and, instead, will appear in follow-up outcomes.
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1
CHAPTER I
INTRODUCTION
Psychotherapy has been proven effective in treating a variety of mental health
issues. However, it is still unclear how psychotherapy works. Component studies are
designed to help researchers identify the active ingredients that are responsible for the
benefits yielded by a full treatment protocol (Ahn & Wampold, 2001; Borkovec, 1990).
A component design involves splitting the therapeutic elements comprising a treatment
and delivering them in separate components of therapy. This design can be delivered
either to different groups or to the same participants in sequence to evaluate the
effectiveness of specific active ingredients (Longmore & Worrell, 2007). The aim of this
project is to determine whether component studies generally find differences in outcome
among dismantled treatment components and the full treatment protocol. This issue was
addressed in an earlier meta-analysis by Ahn and Wampold (2001), but the present study
provides a more comprehensive, updated meta-analysis.
The psychotherapy research field has moved from debating whether
psychotherapy is effective in the treatment of psychological disorders (e.g., Eysenck,
1952) to debating how and why psychotherapy is effective. Although, meta-analytic
investigations (e.g., Smith & Glass, 1977; Smith, Glass, & Miller, 1980) have shown that
most therapeutic practices are generally effective for treating a wide range of clinical
disorders (Task Force on Evidence-Based Practice in Psychology, 2006), there is still
disagreement among researchers about whether client improvement is due to specific
ingredients of treatments (e.g., Eysenck, 1994; Giles, Neims, & Prial, 1993; Strupp,
1986) or to factors common in all therapies (e.g., Ahn & Wampold, 2001; Frank & Frank,
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1991; Garfield, 1998; Task Force on Evidence-Based Practice in Psychology, 2006;
Wampold, 2001). Advocates for empirically supported treatments (ESTs) believe that
specificity (i.e., attributing to specific ingredients) is key to the therapeutic process. The
EST movement supports a process that begins with formulating theories to explain
disorders, problems, or complaints; designing treatments that contain specific ingredients
that are based on the theories formulated; and finally testing the treatments through
randomized controlled trials (RCTs). In an RCT design, participants are randomly
assigned either to an experimental treatment, a standard practice comparison, or a control
condition. The control condition consists of either no treatment or a placebo treatment. At
the end of the study, the outcomes of the experimental treatment group are compared to
the control condition outcomes or the standard practice comparison to determine if the
experimental treatment worked better (Sibbald & Roland, 1998). If the treatment is
supported through RCTs, then the benefits of psychotherapy are attributed to the specific
ingredients that were originally posited (Castelnuovo, Faccio, Molinari, Nardon, &
Salvini, 2004; Wampold, 2001).
Critics of this approach believe that common factors (i.e., healing context,
working alliance, belief in rationale for treatment and in treatment itself) are responsible
for treatment benefits. Advocates of the common factor approach emphasize the
commonalities among therapies. Wampold (2001) wrote:
All therapies involve the relationship of a client and therapist, each of whom
believes in the efficacy of the treatment. The therapist provides the client with a
rationale for the disorder and administers a procedure that is consistent with
that rationale. The client discusses the most intimate details of his or her life,
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confident that the therapeutic relationship will continue. The particular specific
ingredients contained in the treatment, according to the contextual model, are not
responsible for therapeutic benefits. (p. xii)
Critics of the specific ingredients approach, often point to the “Dodo Bird Verdict” to
support their claims that common factors are the causal proponents of change in
psychotherapy. The “Dodo Bird Verdict” derived from Rosenzweig’s (1936) seminal
survey when he concluded that there were “some implicit common factors in diverse
methods of psychotherapy” that were so pervasive that the differences between types of
therapy treatment would be very small (p. 412). He summarized this assertion by quoting
Alice in Wonderland, “everybody has won, so all shall have prizes,” which was the Dodo
bird’s verdict after judging the race (Luborsky et al., 2002, p. 1). Rosenzweig’s theory
that common factors are the key to psychotherapy success has gained support from metaanalyses of comparative studies (Luborsky et al., 2002; Luborsky & Singer, 1975;
Wampold et al., 1997) in which one type of psychotherapy is compared to a different
type of psychotherapy to see which one is more effective in treating clients. For example,
a comparative study could compare cognitive behavioral therapy to interpersonal therapy
for the treatment of depression. In general, these meta-analyses found that although
psychotherapy was more effective than no therapy, the type of psychotherapy did not
make a significant difference on treatment outcome measures.
In 1995, the APA Division 12 (Clinical Psychology) Task Force on Promotion
and Dissemination of Psychological Procedures published criteria for identifying
empirically validated treatments (eventually renamed empirically supported treatments)
for particular disorders (Evidence-Based Practice in Psychology, 2006). The Division 12

4
Task Force described this publication as an effort to promote treatments delivered by
psychologists, because there was a perception in the health field that psychological
treatments were ineffective or inferior to pharmacological treatment (Evidence-Based
Practice in Psychology, 2006). The criteria used by the Division 12 Task Force sparked
controversy after they published a report identifying 18 treatments whose empirical
support they considered to be well established. The criteria for being a well-established
treatment included a treatment having been tested in RCTs with a specific population and
implemented using a treatment manual (Evidence-Based Practice in Psychology, 2006).
Some psychologists argued that conducting research using RCTs and trying to
identify specific active ingredients may harm research and the practice of psychotherapy
because it underemphasizes the common variables that may be the agents for
effectiveness in therapy. Garfield (1998) argued that although we should conduct
research and the efforts of the Division 12 Task Force should be applauded, the scientific
method being used is biased toward manualized treatments that dominate the field.
Garfield (1998) went on to say that this approach is an “attempt to certify and mandate
the use of such therapies prematurely… and by emphasizing the name or form of
psychotherapy, essentially to minimize the importance of patient variability and therapist
skill” (p. 121).
Although advocates of both sides want to learn about the active ingredients that
lead to positive change in the therapeutic process, the proponents of specific factors
believe that these specific factors or techniques may be responsible for the therapeutic
successes of psychotherapy. It is understandable why some psychologists and
researchers would not like the view that common factors and not specific factors are
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responsible for psychotherapy success. As stated by Frank (1971), “ little glory derives
from showing that the particular method which one has mastered with so much effort
may be indistinguishable from other methods in its effects” (p. 350).
Understanding the active ingredients in psychotherapy appears to be a goal that
all psychotherapy researchers value. Component studies have become the gold standard
for trying to accomplish this goal (Ahn & Wampold, 2001). The present meta-analysis of
component studies examined whether differences are generally found between
dismantled components and the full treatment protocol. If the meta-analysis were to
reveal that there are no differences between components and the full treatment protocol,
then there may be theoretical implications to consider. Specifically, results that show that
there are no differences between components and the full treatment protocol may provide
evidence in favor of common factors being responsible for change more than specific
factors. Also, such findings may suggest that the research design currently utilized in
most component studies is not as useful as believed.
History of Component Designs
Psychotherapy research is conducted using several research designs that have
evolved over time. Psychotherapy designs have included comparing treatment to notreatment conditions, comparing treatment conditions to placebo conditions, or
comparing treatment conditions to alternative treatments. Establishing specific causal
factors has been a struggle because, although most psychotherapy designs can draw a
cause-and-effect conclusion, it remains unclear what specific causal factors within the
therapy are responsible for the change (Borkovec & Castonguay, 1998).
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In the 1960s, systematic desensitization became a widely accepted treatment for a
variety of anxiety disorders. Even though there was a large amount of empirical support
behind the use of systematic desensitization, it was unclear which of the different
variables composing the treatment was causing the behavioral change. The developer of
systematic desensitization, Wolpe, theorized that the change in behavior was due to an
underlying neural process called “counter-conditioning” or “reciprocal inhibition” that
required all components of the treatment to be effective (Davison, 1968, p. 92). The
research supporting systematic desensitization used comparative designs comparing
systematic desensitization to alternative therapy, placebo therapy, or no treatment.
Although there was support that the treatment worked better than no treatment/placebo or
alternate conditions, there was not clear evidence that counter-conditioning was the
process causing change. In a review of laboratory studies, Lang (1969) suggested a
method for analyzing desensitization. He wrote:
Perhaps the most prevalent approach involves a sequential dismantling of the
basic treatment unit. This approach is rather like that of a curious aborigine who
hopes to understand a modern automobile. Clinical reports tell him that it runs.
He has even taken it out for a spin. But he does not understand what makes it go.
His plan is to start pulling things off it (perhaps starting with the shiny hood
ornament) until it stops, hoping that he will come to know what parts are critical
to its functioning- and that the owner will not mind too much the mess he has
made of things. (pp. 161-162)
Davison (1968) was the first to test Wolpe’s theory of how systematic
desensitization worked using a dismantling approach. Davison asserted that until tested it
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was possible that the favorable outcomes could be due to relaxation alone, to the gradual
exposure to aversive stimuli, or to nonspecific relationship factors. He developed the first
component study by “dismantling” systematic desensitization into different treatment
groups composed of the different components of therapy and comparing them. Davison
recruited 28 female volunteers from a junior college who reported being very afraid of
nonpoisonous snakes. The study divided the women into four treatment groups. The first
group received the whole desensitization package. The second group called pseudodesensitization received relaxation but no exposure. The third group received an
exposure treatment without relaxation, and the fourth group was not given any treatment.
Davison found a significant difference between the groups that received the full treatment
package and the groups that only received part of the package. The finding that the full
treatment package worked better than any of the parts alone provided evidence for
Wolpe’s theory of counter-conditioning. Follow-up studies (e.g., Miller & Nawas, 1970;
Nawas, Welsh, & Fishman, 1970) used the same dismantling design as Davison’s (1968)
study and provided evidence that relaxation was not an important component to
systematic desensitization in the treatment of snake phobia. Furthermore, in 1975, Marks
reviewed all of the empirical literature and concluded that it was the graded exposure in
systematic desensitization that was the key element in treating phobias (as cited in Tryon,
2005).
This new dismantling design, termed a component study, provided a way to test
theory and provide evidence for active ingredients in treatment packages. Component
studies can be conducted by using either a dismantling design or an additive design (e.g.,
Ahn & Wampold, 2001; Borkovec, 1990; Borkovec & Miranda, 1999). As demonstrated

8
by the Davison (1968) study, dismantling studies are designed to help researchers
identify the active ingredients that are responsible for the benefits yielded by a full
treatment protocol (e.g., Ahn & Wampold, 2001; Borkovec & Miranda, 1999). A
dismantling design involves splitting the therapeutic elements comprising a treatment and
delivering them in separate components of therapy. If the treatment component without
the “specific active ingredient” results in a less successful outcome than the complete
treatment package, then the researcher can conclude that there is evidence that the active
ingredient is key to the effectiveness of the treatment (e.g., Ahn & Wampold, 2001;
Borkovec & Castonguay, 1998; Borkovec & Miranda, 1999). Additive designs add a
specific ingredient to a treatment to see if this ingredient increases the effectiveness of a
particular treatment. The idea behind the additive design is that each component in
psychotherapy is “partially effective” so that the combination of these partially effective
components will lead to a more powerful treatment than any component alone (e.g., Ahn
& Wampold, 2001; Borkovec, 1990; Borkovec & Miranda, 1999).
Through these two types of designs, component studies can provide evidence of
specificity. In an additive design, evidence of specificity is provided when the added
component increases the overall effectiveness of the full treatment package. In a
dismantling design, evidence of specificity is provided when dismantling one component
reduces the effectiveness of the full treatment. Advocates of these designs argue that
component designs are superior to designs in which two treatment packages are
compared, because they provide specific conclusions about causal factors, and they
provide greater control over many extraneous variables that hinder and confound
interpretations of outcome (Borkovec & Miranda, 1999). Comparative designs can
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provide evidence that a particular therapy caused a degree of change beyond the amount
of change caused by factors common to all therapy and beyond the alternative therapy
(Borkovec & Castonguay, 1998).
In addition to component studies being used to provide evidence for active
ingredients, they also have been used to debunk certain components of a treatment. Most
notably, component studies have been used to examine the eye movement component
within Eye Movement Desensitization and Reprocessing (EMDR) therapy. Because
many mainstream psychotherapy researchers have suspected that the eye movement
component of EMDR is grounded in pseudo-science (e.g., Herbert, 2000), several
component studies have been conducted to demonstrate that the eye movement
component is not an active ingredient in treatment.
Controversy over the interpretation of component studies began after Jacobson et
al. (1996) used a dismantling design to examine the active ingredients of cognitivebehavioral treatment for depression. Cognitive-behavioral therapy includes several
interventions that address observable behavior, dysfunctional automatic thoughts, and
inferred underlying cognitive structures or schemas. Cognitive-behavioral therapy is
given in a sequence that starts with changing overt behavior (i.e., behavioral activation),
then moves to teaching the client to assess and correct situation-specific distortions in
thinking (i.e., modification of automatic thoughts), and finally teaching the client to
identify and modify negative core beliefs (i.e., schema therapy; Jacobson et al., 1996).
Jacobson and colleagues (1996) randomly assigned 150 outpatients with major
depression to groups of Behavioral Activation (BA) alone, Behavioral Activation plus
modification of automatic thoughts (AT), or the full Cognitive Therapy (CT) package.
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Jacobson et al. (1996) found no differences between the treatment groups. They
interpreted this finding as evidence that BA is the essential effective ingredient of CT.
Rehm (2009) disagreed with this logic, asserting that dismantling studies generally
do not find differences between the dismantled components and the full treatment. Rehm
(2009) suggested that the lack of differences could be due to methodological problems
with the dismantling design. Specifically, Rehm (2009) suggested two possible reasons
for the lack of differences. First, given that most studies have multiple, complex
components, it is possible that clients may respond to the same component in different
ways or may respond to different components in the same way. Second, Rehm stated that
it might be difficult to find differences in components if they are presented sequentially.
For example, Rabin, Kaslow, and Rehm (1984) compared three versions of self-control
therapy for depression on 104 women who met criteria for a major affective disorder.
The researchers examined the patterns of change for 13 symptoms of depression. They
found that most symptoms diminished in the first 3 to 4 weeks of therapy, and several
symptoms (e.g., sadness and suicidal ideation) showed major reductions prior to the first
session. Rabin et al. (1984) found that components presented at the beginning of therapy
led to greater reduction in symptoms of depression than those presented later in therapy.
If components presented earlier in therapy contribute more to treatment outcome than
those presented later, then components presented earlier may be deemed the active
ingredient due to order effects rather than superiority over other components. In contrast,
if the study is one of a direct comparison, results may be more likely to indicate that both
treatments were effective. If component studies consistently fail to reject the null
hypothesis (i.e., fail to find significant differences between treatment conditions), then
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the use of component studies in general needs to be questioned as a method of evaluating
treatment components. Further, conclusions by researchers about treatment components
based on component studies showing no treatment differences would also need to be
made with extreme caution.
Component Studies Reviews
To date, only one meta-analytic study (Ahn & Wampold, 2001) has examined
differences between treatment components and the full protocol in dismantling and
additive studies. Ahn and Wampold (2001) conducted a meta-analysis on 20 components
studies published in Behaviour Research and Therapy, Behavior Therapy, Journal of
Consulting and Clinical Psychology, and Journal of Counseling Psychology from the
years of 1990 to 1999. Ahn and Wampold (2001) used these four journals after they
referenced a meta-analysis of comparative studies conducted by Shapiro and Shapiro
(1982) and found that most outcome research came from these journals. The researchers
concluded that including all component studies published in these four journals would be
a comprehensive search of the literature. After coding the various component studies,
Ahn and Wampold (2001) used an aggregate of the effect sizes of 27 comparisons by
weighting each study’s estimate of the effect size by the inverse of the variance to yield
the aggregate effect size estimate. Ahn and Wampold’s 27 comparisons came from 20
studies; therefore, in some cases the same full treatment was compared to more than one
dismantled treatment. This method violates the independence assumption. For example
in the Jacobson et al. (1996) study, the full treatment package (Behavioral Activation and
Automatic Thoughts) was compared to two different component treatments (Behavioral
Activation or Automatic Thoughts). Instead of considering the Jacobson et al. study as
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one study and averaging the Cohen’s ds from each component, Ahn and Wampold
considered each comparison as an independent study, despite the fact that the full
treatment package in each comparison was the same group of participants. Using this
aggregation strategy, Ahn and Wampold (2001) failed to find significant differences
between treatment components and the full protocol (i.e., d+ estimate of -0.20). Ahn and
Wampold also failed to find evidence of heterogeneity among the effect sizes. This
finding of homogeneity suggests that there were no important variables moderating the
effect sizes. Ahn and Wampold (2001) concluded from this finding, “the benefits of
treatments are probably due to the pathways common to all bona fide psychological
treatments” (p. 255).
Longmore and Worrell (2007) conducted a literature review of 13 component
analysis studies that examined cognitive behavior therapy (CBT). Specifically, they were
interested in whether specific cognitive interventions increased the effectiveness of
therapy. In their review, Longmore and Worrell found little evidence to support the idea
that specific cognitive interventions significantly increase the effectiveness of therapy. In
fact, “the review showed that, almost without exception, component studies found no
difference in effectiveness between the cognitive and behavioral elements of CBT” (p.
184). Consistent with Ahn and Wampold’s (2001) position, Longmore and Worrell
(2007) suggested that common, nonspecific therapy factors, rather than the active
ingredients, may be responsible for why results generally show little or no differences
between conditions in treatment component studies. The Jacobson et al. (1996) study was
the only study included in both Ahn and Wampold’s (2001) meta-analysis and Longmore
and Worrell’s (2007) review of component studies, which means that there are at least 12
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relevant component studies just on CBT that were not included in the Ahn and Wampold
meta-analysis. A review of the EMDR literature by Herbert et al. (2000) provided a list of
12 EMDR component studies. Only one of these studies was included in Ahn and
Wampold’s meta-analysis, which means there are at least 11 relevant EMDR component
studies that were not included in Ahn and Wampold’s original analysis. The purpose of
most of these component studies was to prove that eye movement is not an active
ingredient in EMDR. Therefore, the inclusion of these additional EMDR studies could
dilute findings and, although the EMDR component studies should be included, they also
should be coded for analysis as a possible moderator.
Present Study
Given the presumption that component studies are a gold standard of
experimental design in psychotherapy research (e.g., Ahn & Wampold, 2001; Wampold,
2001), it is important to examine the validity of this belief empirically. Component study
designs may not provide researchers with as much information as generally thought. As
mentioned earlier, Ahn and Wampold (2001) are the only researchers who have
conducted a meta-analysis of this topic, and they failed to find significant differences
between treatment components and the full protocol. Although the findings were
noteworthy, the research literature has expanded in the past 10 years. Thus, the present
review is an appropriate update and extension of the work by Ahn and Wampold (2001).
The primary aim of this project was to determine whether component studies generally
find differences in outcome among dismantled treatment components and the full
treatment protocol. Given that the previous meta-analysis failed to find significant
differences between the components and the full treatment package and that
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psychotherapy research in general has failed to find significant differences between
psychotherapies, it was hypothesized that there would be very small differences between
treatment components and the full treatment protocol. The present study provides a more
comprehensive, updated meta-analysis since the last study conducted by Ahn and
Wampold (2001). They used 20 studies from four journals (Behavioral Research and
Therapy, Behavior Therapy, Journal of Consulting and Counseling Psychology, and
Journal of Counseling Psychology) published between 1990 and 1999. The present study
included studies from a wider range of sources and included literature that has been
published since the meta-analysis by Ahn and Wampold (2001). In summary, the present
study evaluated the following hypotheses:
1. There are generally no differences between the outcomes in treatment studies
comparing a dismantled component to the full treatment package as indicated by
an effect size near zero.
2. Results from the studies will be homogeneous.
3. If heterogeneity is found it may be moderated by treatment type, specifically
EMDR versus non-EMDR.
In addition, a planned exploratory analysis was conducted to determine if a
difference in effect sizes for follow-up outcome data was found between treatment
studies comparing a dismantled component to the full treatment package. Because this
was an exploratory analysis, no a priori hypothesis was made.
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CHAPTER II
METHOD
Compilation of Studies
There were no original participants in this study, as it is a meta-analysis of existing
literature. All the studies included in the Ahn and Wampold’s (2001) meta-analysis were
included in the present study. Furthermore, the four journals identified in their metaanalysis were searched by hand, via a review of each table of contents, for any relevant
articles published between the end of their review (1999) and 2010. Ten out of twelve
studies from Longmore and Worrell’s (2007) literature review on component studies also
were included in the present meta-analysis. One study was excluded because it provided
two-year follow-up data of a study already included in this study and the other study
examine did not use a component design to examine the active ingredients. Because a
number of studies have examined whether eye movement is an essential component of
Eye Movement Desensitization and Reprocessing (EMDR), component studies that met
criteria from the Herbert et al. (2000) literature review of EMDR were also included in
the meta-analysis. Finally, a search for relevant literature was conducted with
PsychINFO and Medline. The search terms originally planned in the proposal had to be
adjusted and limited due to very large search returns. Therefore, the combination of the
search terms “dismantling” and “treatment” was used. These combined searches yielded
142 possible references. Any studies that met inclusion criteria and were not already
captured by the journal searches were included in the meta-analysis.
The study used the same criteria for identifying relevant component studies as
Ahn and Wampold’s (2001) study (see Appendix A for details). In addition to the study
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criteria listed by Ahn and Wampold in Appendix A, studies must have been written in
English, produced codable data, and included a measure of treatment effect for each
component in the dismantling studies. Single case designs were excluded. Studies were
not excluded if they did not specify a Master’s level therapist (as referenced in Appendix
A); rather, studies were included as long as the therapy was provided by a graduate level
student or a therapist supervised by a professional in the field.
Fifty-eight studies met the inclusion criteria and were used in the meta-analysis.
One of the articles (Nicholas et al., 1991) counted as two studies because it reported two
different component studies within the one article. This one article by Nicholas et al.
(1991) had two different full treatment packages that were compared to two different
dismantled components. Thus the meta-analysis included 59 studies that included 3,213
children, adolescents, and adults. All studies included in the meta-analysis are listed in
Table 1.
Procedure
Once included, the studies were coded on a variety of dimensions including
sample size, study design, sample type, method of measuring outcome, problem type
(e.g., depression, anxiety), intervention type (e.g., cognitive-behavioral therapy,
interpersonal therapy), components, client age, client gender, location of therapy (i.e.,
inpatient, outpatient), and year of publication (see Appendix B).
For each DV, a sample effect size was obtained by calculating the difference in the
means of the two conditions and dividing by the pooled standard deviation (morecomponent-group M- fewer-component-group M)/SD. Typically, higher scores on
outcome measures (dependent variables; DVs) indicate greater distress or pathology;
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however, on occasion a higher score would indicate something positive (e.g., selfesteem). In these cases, the scoring was reversed so that a higher score represented
greater impairment (e.g., lower self-esteem) to maintain consistent direction of change
across studies. Therefore, a negative effect size indicates that the full treatment was
superior to the dismantled treatment. If a study provided more than one DV, the DVs
were averaged, and the average was used instead of multiple DVs. If, however, a study
provided some DVs specific to the problem and some DVs that were more general, only
the DVs that were specific to the problem being treated were included in the average. In
the situation in which a study only reported the composite results from several outcome
measures, the composite was the value included in the meta-analysis. Effect sizes were
weighted by the inverse variance so that studies with larger samples had greater weight.
To determine whether effect sizes were from a single population, a Q test of homogeneity
was calculated. If Q was statistically significant, the homogeneity hypothesis would be
rejected. In addition to the Q test of homogeneity, I2 (Higgons, Thompson, Deeks, &
Altman, 2003) was calculated. I2 describes the amount of variance attributable to
heterogeneity across the studies. An I2 value of 0 would indicate absolute homogeneity
among the studies, whereas 100 would indicate complete heterogeneity. When the effect
sizes were found to be heterogeneous, potential moderators—including client type, type
of intervention (specifically whether the treatment was an EMDR dismantling study),
gender, year of publication, and age—were examined. Hedges’ (1982) meta-analytic
equivalent to a one-way ANOVA was used to examine categorical moderators (e.g.,
client type), and Hedges and Olkin’s (1985) meta-analytic equivalent to multiple
regression was used to examine continuous moderators (e.g., age).
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The choice of which type of model to use in a meta-analysis depends on the
inferences the researcher wants to make. If the researcher wants to make inferences only
about the studies included, a fixed effects model would be appropriate. However, the
present meta-analysis aimed to infer beyond the included studies and generalize to the
population of component studies. Therefore, a random effects model was the most
appropriate choice (Field, 2003). That is, random effects models assume that the studies
included in the meta-analysis do not constitute all the studies that could exist (Field,
2003). Additionally, a random effects model allows for sampling errors by including
both between-study and within-study variance in the error term. In contrast, a fixed
effects model includes within-study variance and “assume all other ‘unknowns’ in the
model are constant” (Field, 2003, p. 107). All analyses were conducted using Lipsey and
Wilson’s (2001) SPSS statistical programs.
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CHAPTER III
RESULTS
Is the Full Treatment Superior to the Dismantled Treatment at Completion?
The first hypothesis posited that dismantled components would not differ from the
full treatment package in treatment outcomes. This hypothesis was confirmed. In studies
where different components were removed and each variation was compared to the full
treatment, the effect sizes were calculated for each variation compared to the full package
and then averaged together to obtain the study’s average component d, so that each study
yielded a single d. This strategy was used to avoid violating the assumption of
independence. The average d across all 59 studies was -.005, which was trivial and not
statistically significant (95% CI = -.09 - .08; Z = -.102, p = .91).
The second hypothesis (i.e., that there would be no heterogeneity among the
studies) was not supported. Indeed, there was considerable heterogeneity among these
studies, Q (58) = 77.4717, p = .045, I2 = 25.1, suggesting that they do not all derive from
the same population. Because of the significant heterogeneity across the studies, further
analyses examined potential moderators that may explain some of the variability.
The analyses were also conducted using the same method that Ahn and Wampold
(2001) used in their meta-analysis. Ahn and Wampold did not average component
comparisons within a treatment study (for an average d) and instead treated each
component comparison variation as a different study outcome, violating the assumption
of independence. There were 76 comparisons within the 59 studies. An analysis using
Ahn and Wampold’s method of calculating d did not change the results. Specifically, the
average d across all 76 comparisons was -.025, which also was trivial and not statistically
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significant (95% CI = -.11 - .06; Z = -.566, p = .574). Consistent with the previous
analysis, there was considerable heterogeneity among these studies, Q (75) = 111.6903, p
= .0039, I2 = 32.85, suggesting that the studies do not all derive from the same
population.
A final effect size was computed by selecting the d that most favored the full
treatment against whichever variation had the poorest outcome. Although this approach
risked overstating the superiority of the full treatment, by possibly capitalizing on chance,
it was the most rigorous test of the first hypothesis (i.e., that there would be no difference
between the full treatment and a dismantled treatment). The averaged d across the 59
studies was -.039, which was still trivial and not statistically significant (95% CI = -.13 .06; Z = -.802, p = .423). Again, there was considerable heterogeneity among these
studies, Q (58) = 84.3616, p = .0135, I2 = 31.24, suggesting that they do not all derive
from the same population. Overall, across all analyses, there was no evidence that the
full treatment was superior to a dismantled treatment at treatment completion.
Can the Variations across Study Outcomes be Explained?
Several demographic variables were explored as potential moderators. The analyses
of moderators were conducted using the data from the first method of analyses (i.e., the
ds were calculated for each variation compared to the full package and then averaged
together to obtain the study’s average component d, so that each study yielded a single d).
The role of client type (whether the participant was a client or a volunteer), gender, and
age were all assessed as potential moderators. Client type (k = 59) did not account for the
variability across studies, QB (1) = .236, p = .628; QW (57) = 63.465, p = .259. The
percent of male participants (k = 57) was assessed as a potential moderator, but gender

21
did not moderate the difference between the full treatment package and the component
packages (β = .038; B = .001 [SE = .0016]; Z = .291, p = .771). When average age of the
sample (k = 50) was treated as a continuous moderator, the meta-analytic analogue to a
regression yielded a significant effect for age (β = -.319; B = -.008 [SE = .0034]; Z = 2.419, p = .016): The full treatment was more likely to yield superior outcomes in those
studies in which the clients were older.
Because age was found to significantly moderate the outcome differences between
the component group and the full treatment package at the end of the treatment, a scatter
plot graph was used to visually assess for any outliers that may have influenced these
findings. One possible outlier (Nezu & Perri, 1989) was identified: This study’s z-score
was the only z-score that was more than three standard deviations from the mean.
Therefore, an additional analysis was conducted excluding this study. Even when the
outlier was excluded from the analysis, the regression remained significant, (β = -.296; B
= -.007 [SE = .0034]; Z = -2.042, p = .0411). Since age was not found as a moderator in
the original study by Ahn and Wampold (2001), an independent sample’s t-test was used
to compare average age in the two meta-analyses. The studies from the Ahn and
Wampold meta-analysis had a mean of 34.92 (SD = 11.46) while the studies added for
the current meta-analysis had a mean of 33.73 (SD = 9.76). No significant differences
were found between the Ahn and Wampold (2001) meta-analysis (t = .393, p = .696) and
the current meta-analysis for the average ages of clients participating in the studies
included.
Year of study publication (k = 59) was examined as a possible moderator. The
studies included in the meta-analysis were published between 1989 and 2010. The year
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of publication was not a significant moderator, (β = .0058; B = .0003 [SE = .007]; Z =
.046, p = .96).
As mentioned earlier, there was a concern that the EMDR debunking studies may
have diluted any full treatment package superiority by washing out differences between
full treatment packages and component treatments. In order to assess whether EMDR
studies could have moderated treatment outcomes, the studies were coded categorically
for treatment type. Specifically, studies were assigned a number to categorize them as an
EMDR treatment study versus a non-EMDR treatment study. Treatment type did not
moderate the results, QB(1) = .088, p = .767; QW(57) = 62.26, p = .295. Both the EMDR
studies’ findings, d (10) = .0308 (95% CI = -.21 - .27; Z = .257, p = .80) and the nonEMDR studies’ findings d (49) = -.0080 (95% CI = -.10 - .09; Z = -.17, p = .87),
indicated no difference between the full treatment package and the component package.
Is the Full Treatment Superior to the Dismantled Treatment at Follow-Up?
Forty-four of the studies that reported comparisons between components and the
full treatment package also provided appropriate follow-up data. Therefore, although no
a priori hypothesis was made, potential differences between components and the full
treatment package at follow-up were explored. If a study reported several follow-up data
points, the follow-up point closest to six months was used to compute the effect size. The
average d across all 44 comparisons at follow-up was -.159, (95% CI = -.26 - .06; Z = 3.01, p = .003). Although -.159 is generally considered a small effect (Cohen, 1988), it
was significant. Despite the findings that there were no differences at treatment
completion, this significant effect suggests the clients who received the full treatment
package did better at follow-up than the clients in the component groups. These studies
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were not heterogeneous [Q (43) = 46.7187, p = .322, I2 = 7.9%], suggesting that they
were drawn from the same population. Therefore, no moderator analyses were conducted
on the follow-up studies.
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CHAPTER IV
DISCUSSION
Overall Findings of Present Meta-Analysis
From these results, it can be concluded that initially treatment dismantled
components do not differ in effectiveness from the full treatment package. Individuals
who were treated with a component treatment ingredient did not differ from individuals
treated with the full treatment package at the end of treatment. These results supported
the original hypothesis that there would be very small differences between the dismantled
component and the full treatment package. The finding that there was considerable
heterogeneity among the studies was not predicted and suggests that there may be
moderating variables that explain why the studies yielded different outcomes. In the
present analysis, age was identified as a moderator: The full treatment was more
effective than the dismantled treatment in those studies that had older participants. In
addition to the original hypotheses that were proposed, an exploratory analysis yielded an
unexpected finding that full treatment packages had better outcomes than the dismantled
treatment components at the follow-up assessments. It can be concluded from the followup data that, in general, full treatment packages have better outcomes than component
treatment groups over time.
Comparison With Previous Literature
Although the present meta-analysis replicates some of the findings of Ahn and
Wampold (2001), the study on which it was based, it is important to note that some
inconsistencies were also found (e.g., homogeneity versus heterogeneity). Likewise, the
present study examined some questions that were not addressed by Ahn and Wampold
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(e.g., moderators, follow-up outcomes). Primarily, the finding that there were no
differences between the full treatment package and the component treatment at
termination was consistent with the Ahn and Wampold’s (2001) meta-analysis. In Ahn
and Wampold’s meta-analysis, they concluded that a lack of differences between
component treatments and full treatments was due to nonspecific treatment factors. Ahn
and Wampold argued that the nonspecific factors in therapy are the casual ingredients for
treatment gains. They contended that because nonspecific factors are present in both the
full and component treatments, differences between these two groups would not exist.
The present study’s null findings when comparing components and full treatments lend
support to the idea that nonspecific factors may be responsible for the progress seen at
treatment termination. However, as discussed in more detail below, the present study
examined potential differences in follow-up outcomes—something that was not evaluated
by Ahn and Wampold—and found that specific factors in the full treatment package are
more effective over time.
The finding in the present meta-analysis that the studies were heterogeneous and
moderated by age was inconsistent with Ahn and Wampold’s findings, which found
homogeneity among the studies. It is important to note that, although the present metaanalysis included a relatively small number of studies (k =59), it did include more studies
than the Ahn and Wampold (2001) meta-analysis (k = 20). Therefore, the larger sample
should have more accurately reflected the literature and increased the likelihood that the
studies came from diverse populations, which could explain why the present study found
heterogeneity.
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Because heterogeneity was found in the present study, several potential moderators
were examined. However, only age emerged as a moderator. The finding that older
individuals may benefit more from broader treatments is not a new finding in the research
literature. It is important to note that the “older” group in this sample is referring to
clients in the middle to late-middle age group. The “older” group of individuals would be
in their late 50s. Kennedy and Tanenbaum (2000) reported that although older adults
benefit from many of the standard procedures in therapy, they also have additional needs
and could benefit from more individualized modifications in therapy to address a variety
of areas that are new challenges for them (i.e., family functioning, social functioning,
self-reliance). Additional needs for older individuals may explain why a less complete or
component therapy (e.g., Behavioral Activation) may not be as beneficial to them as the
full treatment package (e.g., Cognitive-Behavioral Therapy) in addressing more specific
individual needs and challenges at a later stage in life. It is also possible that the clients
that come to therapy later in life have more ingrained schemas or core beliefs. For these
clients, the more single-faceted treatments may not address problems that a client has
struggled with for years. A more complete treatment package may offer more tools in
these multiple areas of need.
The present meta-analysis built upon the Ahn and Wampold (2001) study by
exploring differences at follow-up outcomes. Results from the follow-up data indicated a
small but significant effect in favor of the full treatment package. Because the effect size
was small (d = -.159), the magnitude should be addressed when drawing conclusions
about how much of a difference this effect is in terms of treatment. First, the typical effect
sizes in the meta-analyses literature should be considered for the different treatment
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outcome designs. Lambert and Bergin (1994) reported a summary effect size of .48 when
comparing an active psychotherapy to a placebo group (inactive treatment). Effect size
differences drop (typically ranging from just above .00 to less than .21) when the
treatment design is comparing two active treatments (Wampold et al., 1997). Therefore,
an even larger drop in effect size should be expected for the present study, which
compares an active treatment to a variation of that same treatment minus one component.
It is not surprising, then, that the significant effect size found for follow-up outcomes was
small in magnitude.
In further evaluating what this small effect size means, it is helpful to compare it to
other effect sizes in the psychological and medical outcome literature. A comment by
Rosenthal (1990) provides insight on what small effect sizes may mean by providing
several examples of medical research and psychological research (e.g., Barnes, 1986;
Canadian Multicentre Transplant Study Group, 1983; Centers for Disease Control
Vietnam Experience Study, 1988; Smith & Glass, 1977; Steering Committee of the
Physicians Health Study Research Group, 1988) where studies were ended prematurely
due to small effect sizes in favor of the experimental treatment because it would be
unethical to continue providing a placebo to subjects. Although the effect sizes were very
small statistically, the effects were clinically meaningful when considering the number of
people benefiting from treatment compared to the placebo. For example, although r = .10
is typically considered a small effect size, a study examining the effect of aspirin on heart
attacks ended early when an effect size of r = .034 was found because of the large
numbers of heart attacks prevented by taking aspirin. That is, only 104 people in the
aspirin group experienced a heart attack compared to 189 people in the placebo group.
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So, although the effect size of the present study is very small, it is nevertheless
statistically significant and may be quite clinically meaningful.
The unexpected finding that full treatment packages are better than component
treatments at follow-up may offer a more complete picture of why and how the
psychotherapy process works. The finding that there are no differences between
treatment components and the full treatment package at the end of therapy seems to lend
support to the argument against the specificity theory. However, the follow-up outcomes
provide evidence in favor of the full treatment package. The idea that nonspecific factors
alone cause therapeutic change must be challenged with the finding of better full
treatment outcomes at follow-up. One explanation for better full treatment outcomes at
follow-up considers time of measurement as a key factor in outcome results. It is
possible that differences between full treatments and components will have a delayed
effect on treatment outcomes. The positive outcomes seen at the end of therapy may be
due to the nonspecific treatment ingredients. However, it is the long-term gains in
outcomes that can be attributed to specific treatment ingredients.
Several studies (Bush, Kanter, Landes, & Kohlenberg, 2006; Stiles et al., 2003;
Tang & DeRubeis, 1999a, 1999b) looking at treatment outcomes across time found that
the majority of the treatment gains occurred after the first session. The comparative
studies (Luborsky et al., 2002; Luborsky & Singer, 1975; Wampold et al., 1997)
mentioned earlier concluded that there were no differences between different
psychotherapies and that they all led to similar gains, which were attributed to the
nonspecific factors rather than active ingredients. Finally, the results at treatment
completion found in the present meta-analysis as well as the one conducted by Ahn and
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Wampold (2001) also underscore nonspecific factors as paramount. However, there may
be an alternative explanation in which specific active ingredients do lead to specific
changes. First, nonspecific factors are likely responsible for the initial change seen in
clients. If treatment outcomes are only measured once at the end of psychotherapy (often
a 6- to 12-week process), differences between psychotherapy ingredients or treatments
may not be found because it is too early to detect any change beyond the benefits of
nonspecific factors. This possibility is supported by the present study’s findings which
showed that the full packages were more beneficial at follow-up assessment. In other
words, assessment of the initial outcomes may not have allowed enough time for the
clients to demonstrate their benefit from the specific ingredients. Anecdotally, this pattern
mirrors what therapists often describe with their clients in therapy. For example,
cognitive therapists (e.g., Beck, 1995) often use techniques that aim to teach the client to
become their own therapist; however, the process takes practice and the implementation
of many tools over time. With time, the client should become better at being their own
therapist and effectively using the specific techniques, which may be reflected in followup assessments (i.e., as supported by the present study). As such, it may be unreasonable
for researchers and practitioners to expect huge treatment successes in a short amount of
time. A second possibility is that clients who only received dismantled component
packages lost the benefits initially showed at outcomes over time. It could be these less
complete packages do not have the staying power and, therefore, the full package out
performed the component package over time.
The current study contributes to the literature by answering an important question
about the utility of component treatment studies. Component treatment studies are able
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to provide information on active ingredients, but the typical time of measurement (at the
end of treatment) may not be as useful as previously thought. Although it is difficult to
keep clients engaged in research over long time periods due to various challenges, the
present study suggests that it is still important to attempt to obtain longer follow-up data.
Neither component studies nor comparative studies may be able to provide useful
information about particular components if treatment outcomes are limited solely to the
end of treatment. Since clients generally benefit more from the full treatment package at
follow-up, it may not be the best approach to offer only certain components.
Additionally, it may be beneficial to contact clients after termination to collect follow-up
data on their progress. As addressed earlier in this paper, there has been an ongoing
theoretical debate over the mechanisms of change in psychotherapy. The present study
provides evidence that both nonspecific factors (particularly during initial phases of
therapy) and specific ingredients (particularly after time, which would allow practice of
techniques) in therapy contribute to the change seen in treatment outcomes.
Limitations and Future Directions
Although the present study provides important information about component
designs and research outcomes, there are some limitations to consider. First, this metaanalytic review was restricted by the small number of studies (k = 59) included in the
analysis. However, this review did include more studies than the Ahn and Wampold
(2001) review (k = 20). Additionally, the electronic literature search was limited by the
useful search terms available. The search terms originally proposed were too broad,
captured more studies than manageable, and returned irrelevant studies.
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There are also limitations that are inherent to any meta-analytic review. In a metaanalysis, it is preferable to include studies similar enough to be combined. Although all
of the studies included were component studies, which was the research design of
interest, the studies were diverse in treatment approach and treatment problem. Although
the diversity of these studies should increase the external validity or generalizablity of the
findings, it also limits the present study’s internal validity. In addition to ranging in
treatment problem and approach, the studies most likely differ in the quality of the
research conducted. It would have been beneficial to rank the studies on quality of
research; however, doing so would risk introducing bias of the investigator and would not
allow the literature to speak for itself. Finally, author allegiance may not have been
evenly balanced across the studies included. For example, researchers who come from a
certain theoretical perspective may interpret empirical results in a way that complements
their own viewpoint. Although author allegiance is a limitation to any meta-analysis,
there is not a realistic way to code studies for author allegiance.
Given the findings of the present study, future component research should focus on
providing long-term outcome assessments to examine whether evidence to support
specific ingredients exist after a delay in time. Comparative research studies may also
find a difference between treatments with longer follow-up assessments. The discussion
over why psychotherapy works is far from resolved, but the present study provides some
suggestions to move future research in the right direction.
In conclusion, the present meta-analysis indicates that there are no differences in
treatment outcomes between a therapy component treatment and the full treatment
package directly following treatment. However, small but significant differences do exist
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between components and full treatments at follow-up assessments. These differences
favor the full treatment package, indicating that specific ingredients in psychotherapy
may be more effective than just nonspecific factors common to all therapy. It should be
clear from this review that future component studies should include long-term follow-up
assessments.

Table A1

GAD

CT+PMR (n=11)
CT+PMR (n=11)

PMR (n=10)
CT (n=13)

Baucom et al. (1990)

Marital Discord

CR+BMT (n=12)
EET+BMT (n=12)
EET+CR+BMT (n=12)

BMT (n=12)
BMT (n=12)
BMT (n=12)

Bauman & MeInyk (1994)
Blanchard et al. (1990)
Borkovec et al. (2002)

Test Anxiety
Tension Headache
GAD

EMDR (n=15)
CT+PMR (n=16)
CT+SCD (n=23)
CT+SCD (n=23)

FTDR (n=15)
PMR (n=19)
CT (n=23)
SCD (n=23)

Borkovec & Costello (1993)
Bryant et al. (2003)
Bryant et al. (2005)

GAD
PTSD
Acute Stress

CBT (n=18)
IE +CR (n=20)
CBT+hypnosis (n=30)

AR (n=18)
IE (n=20)
CBT (n=33)

APPENDIX A

Barlow et al. (1992)

Effect d
.246
.379
-.108
.136(average d)
.300
.228
.264(average d)
.449
-.202
.485
-.200(average d)
.029
.127
-.054
-.276
-.165(average d)
-.187
-.247
-.037

GENERAL INFORMATION TABLE

General Information on Studies That Examined the Difference between a Full Treatment Package and the Component
More
Fewer
components
components
Study
Disorder
group (n)
group (n)
Applebaum et al. (1990)
Tension Headache
CT+PMR (n=17)
PMR (n=16)
Barlow et al. (1989)
Panic Disorder
PMR+EX+CR (n= 16)
PMR (n=10)
PMR+EX+CR (n=16)
EX+CR (n=15)
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Table A1 (continued).

Study
Bryant et al. (2008)

Disorder
PTSD

Cusack & Spates (1999)
PTSD
Dadds & McHugh (1992)
Child Conduct
De Jong et al. (2000)
Spider phobia
de Zwaan et al. (2005)
Binge eating
Deffenbacher et al. (2002) Angry drivers
Deffenbacher & Stark (1992) General anger
Devilly et al. (1998)
PTSD
Dunn et al. (1996)
Anxiety
Emmelkamp & Beens (1991) OCD
Fesk & Goldstein (1997)
Panic disorder
Flessner et al. (2005)
Nail biting
Foa et al. (2005)
PTSD
Foa & Rauch (2004)
PTSD
Foley & Spates (1995)
Public speaking phobia

More
components
group (n)
IE+In Vivo EX+CT (n=28)
IE+In Vivo EX+CT (n=28)
IE+In Vivo EX+CT (n=28)
EMDR (n=11)
CMT+ Ally (n=11)
EX+CC (n=18)
BT (VLCD)+CBT (n=36)
CRCS (n=17)
CRCS (n=16)
EMDR (n=12)
EMD (n=14)
EX+CT (n=10)
EMDR (n=18)
SHR (n=18)
PE+CR (n=74)
PE+CR (n=27)
EMD (n=10)

EMD (n=10)
Gosselin & Matthews (1995)
Grunes et al. (2001)
Halford et al. (1993)
Hope et al. (1995)

Test anxiety
OCD
Marital Discord
Social phobia

EMD (n=21)
ERP+FI (n=14)
EBMT (n=13)
CBT (n=13)

Fewer
components
group (n)
Effect d
IE (n=31)
-.832
In Vivo EX (n=28)
-1.009
IE+In Vivo EX (n=31) -.775
-.872 (average d)
EMD-R (n=11)
.004
CMT (n=11)
-.185
EX (n=16)
.245
BT(VLCD) (n=35)
.173
RCS (n=16)
-.349
RCS (n=19)
.153
EMDR-EM (n=12)
-.326
No Eye Movement (n=14) -.001
EX (n=11)
-.323
EFER (n=18)
-.002
SHR-social support (n=20) -.144
PE (n=79)
-.079
PE (n=27)
-.218
EX w/ resting eyes (n=10) -.437
EX w/movement to sound (n=10) .526
.045 (average d)
EMD-EM (n=20)
-.120
ERP (n=14)
-.424
BMT (n=13)
.313
Exposure only (n=10)
.253
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Table A1 (continued).
More
components
group (n)
BA+AT (n=49)
BA+AT (n=49)

Fewer
components
group (n)
AT (n=42)
BA (n=55)

Study
Jacobson et al. (1996)

Disorder
Depression

Kazdin & Whitley (2003)
Koch et al. (2004)
Marks et al. (1998)

Child Conduct
PSST+PMT+PPS (n=57)
Small animal phobia CBT+EX (n=20)
PTSD
EX+CR (n=20)
EX+CR (n=20)

PSST+PMT (n=70)
EX (n=20)
EX (n=20)
CR (n=19)

Mattick et al. (1989)

Social phobia

CBT (n=11)
CBT(n=11)

CR (n=11)
EX (n=11)

McKay et al. (2010)
Nezu & Perri (1989)
Nicholas et al. (1991)
Nicholas et al. (1991)
Öst et al. (2004)
Öst et al. (1991)

Cocaine dependence
Depression
Chronic back pain
Chronic back pain
Panic disorder
Blood phobia

RP+CM (n=25)
PST (n=14)
BT+PMR (n=8)
CT+PMR (n=8)
CBT (n=34)
ATP (n=10)
ATP (n=10)

CM (n=26)
APST (n=14)
BT (n=9)
CT (n=7)
EX (n=29)
Tension only (n=10)
EX (n=10)

Paunovic & Ost (2001)
Petry et al. (2008)
Pitman et al. (1996)
Porzelius et al. (1995)
Propst et al. (1992)

PTSD
Gambling problems
PTSD
Eating disorder
Depression

CBT+EX (n=7)
MT+CBT (n=40)
EMDR (n=16)
OBET (n=25)
CBT-Religious (n= 10)

EX (n=9)
MT (n=55)
EMDR-EM (n=14)
CBT (n=21)
CBT (n=10)

Effect d
-.003
.127
.062 (average d)
.323
-.484
.383
.333
.358 (average d)
-.426
-.216
-.321(average d)
.0
-1.295
.795
-1.567
.047
-.356
.149
-.104 (average d)
-.300
-.309
.232
.068
-.364
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Table A1 (continued).

Study

Disorder

More
components
group (n)

Fewer
components
group (n)

Radojevic et al. (1992)

Rheumatoid arthritis BT+social support (n=15)
BT+social support (n=15)

BT (n=14)
Social support (n=15)

Resick et al. (2008)

PTSD

CPT package (n=42)
CPT package (n=42)

CPT-C (n=38)
Written Alone (n=38)

Roehrig et al. (2006)
Rohan et al. (2007)

Body image
SAD

CA+EX (n=30)
CBT+Light Therapy(n=15)
CBT+ Light Therapy (n=15)

CA (n=36)
Light Therapy (n=16)
CBT (n=15)

Rosen et al. (1990)
Body image
Sanders & McFarland (2000) Family behavior
Sanderson & Carpenter(1992)Phobias
Schmidt et al. (2000)
Panic Disorder
Schmiege et al. (2009)
HIV/STD risk
Taylor et al. (2003)
PTSD
Thackwray et al. (1993)
Bulimia nervosa
Walters et al. (2009)
Alcohol problems
Webster-Stratton (1994)

CBTP (n=13)

CBT (n=11)
CBFI (n=23)
BFI (n=24)
EMD (n=32)
EMD-EM (n=30)
CBT+breathing retraining(n=32) CBT (n=21)
GPI+GMET (n=163)
GPI (n=154)
EMDR (n=15)
EMDR-EM (n=15)
CBT (n=13)
BT (n=13)
MI+FB (n=70)
FB (n=57)
MI+FB (n=70)
MI (n= 59)

Parenting effectiveness GDVM+ADVANCE (n=38)

GDVM (n=39)

Effect d
-.224
-.121
-.180 (average d)
.099
-.348
-.125 (average d)
.339
.478
.469
.473 (average d)
.183
.980
-.086
-.368
.242
.633
.760
.054
-.092
-.019(average d)
-.122
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Table A1 (continued).

Study
Williams & Falbo (1996)

Disorder
Panic Disorder

More
components
group (n)

Fewer
components
group (n)

CBT (n=11)
CBT (n=11)

BT (n=10)
CT (n=13)

Effect d
.093
.050
.072 (average d)

Note. Disorder: GAD = Generalized Anxiety Disorder, PTSD = Post Traumatic Stress Disorder, OCD = Obsessive-Compulsive Disorder, SAD = Seasonal Affective Disorder, HIV = Human
Immunodeficiency Virus, STD = Sexually Transmitted Disease. Component Group: CT = Cognitive Therapy; PMR = Progressive Muscle relaxation; EX = Exposure Therapy; CR = Cognitive
Restructuring; BMT = Behavioral Marital Therapy; EET = Emotional Expressiveness Training; EMDR = Eye Movement Desensitization Reprocessing; FTDR= Finger Tapping Desensitization
Restructuring; SCD = Self-Control Desensitization; AR = Applied Relaxation; CBT = Cognitive-Behavioral Therapy; IE = Imaginal Exposure; EMD-R = Eye Movement Desensitization without
Reprocessing; CMT = Child Management Training; CC = Counter Conditioning; BT = Behavior Therapy; VLCD = Very Low Calorie Diet; CRCS = Cognitive and Relaxation Coping Skills; RCS =
Relaxation Coping Skills; EMD = Eye Movement Desensitization; EFER = Eye Fixation Exposure and Reprocessing; SHR = Simplified Habit Reversal; PE = Prolonged Exposure; ERP = Exposure and
Response Prevention; FI = Family Involvement; EBMT= Enhanced Behavioral Marital Therapy; BA = Behavioral Activation; AT = Automatic Thoughts; PSST = Problem Solving Skills Training; PMT
= Parent Management Training; PPS = Parent Problem Solving; RP = Response Prevention; CM = Contingency Management; PST = Problem Solving Therapy; APST = Abbreviated Problem Solving
Therapy; ATP = Applied Tension Package; MT = Motivational Techniques; CPT = Cognitive Processing Therapy; CPT-C = Cognitive Processing Therapy without the written component; CA =
Counter Attitudinal Therapy; CBTP = Cognitive-Behavioral Therapy with Perception Training; CBFI = Cognitive-Behavioral Family Intervention; BFI = Behavioral Family Intervention; GPI = Theory
based sexual risk reduction intervention; GMET = Group Based Motivational Enhancement Therapy; MI = Motivational Interviewing; FB = Feed Back; GDVM= videotaped parent skills training
program; ADVANCE = cognitive training social learning program.
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Table B1
Follow-Up Information on Studies That Examined the Difference between a Full Treatment Package and the Component
Fewer
components
group (n)
PMR (n=10)
EX+CR (n=15)

Disorder
Panic Disorder

Baucom et al. (1990)

Marital Discord

CR+BMT (n=12)
EET+BMT (n=12)
EET+CR+BMT (n=12)

BMT (n=12)
BMT (n=12)
BMT (n=12)

Borkovec et al. (2002)

GAD

CT+SCD (n=23)
CT+SCD (n=23)

CT (n=22)
SCD (n=21)

Borkovec & Costello (1993)
Bryant et al. (2003)
Bryant et al. (2005)
Bryant et al. (2008)

GAD
PTSD
Acute Stress
PTSD

CBT (n=17)
IE +CR (n=20)
CBT+hypnosis (n=23)
IE+In Vivo EX+CT (n=21)
IE+In Vivo EX+CT (n=21)
IE+In Vivo EX+CT (n=21)

AR (n=17)
IE (n=20)
CBT (n=24)
IE (n=21)
In Vivo EX (n=21)
IE+In Vivo EX (n=21)

Dadds & McHugh (1992)
De Jong et al. (2000)
Deffenbacher et al. (2002)

Child Conduct
Spider phobia
Angry drivers

CMT+ Ally (n=6) CMT (n=5)
EX+CC (n=12)
CRCS (n=17)

EX (n=12)
RCS (n=16)

Effect d
.189
.567
.378 (average d)
-.032
.043
.026
.012 (average d)
-.174
-.359
-.267 (average d)
-.077
-.357
-.017
-.899
-.927
-.732
-.853 (average d)
-.173
.237
-.025

APPENDIX B

Study
Barlow et al. (1989)

FOLLOW-UP INFORMATION TABLE

More
components
group (n)
PMR+EX+CR (n= 16)
PMR+EX+CR (n=16)
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Table B2 (continued).

Study
Disorder
Deffenbacher & Stark (1992) General anger
Devilly et al. (1998)
PTSD
Emmelkamp & Beens (1991) OCD
Fesk & Goldstein (1997)
Panic disorder
Foa et al. (2005)
PTSD
Foa & Rauch (2004)
PTSD
Grunes et al. (2001)
OCD
Halford et al. (1993)
Marital Discord
Hope et al. (1995)
Social phobia
Jacobson et al. (1996)
Depression

More
components
group (n)
CRCS (n=12)
EMDR (n=13)
EX+CT (n=10)
EMDR (n=14)
PE+CR (n=42)
PE+CR (n=18)
ERP+FI (n=14)
EBMT (n=13)
CBT (n=9)
BA+AT (n=47)
BA+AT (n=47)

Fewer
components
group (n)
RCS (n=14)
EMDR-EM (n=12)
EX (n=11)
EFER (n=14)
PE (n=47)
PE (n=20)
ERP (n=14)
BMT (n=13)
Exposure only (n=8)
AT (n=39)
BA (n=50)

Koch et al. (2004)
Marks et al. (1998)

Small animal phobia CBT+EX (n=20)
PTSD
EX+CR (n=11)
EX+CR (n=11)

EX (n=20)
EX (n=12)
CR (n=12)

Mattick et al. (1989)

Social phobia

CBT (n=10)
CBT(n=10)

CR (n=9)
EX (n=10)

McKay et al. (2010)
Nezu & Perri (1989)
Nicholas et al. (1991)
Nicholas et al. (1991)
Öst et al. (2004)

Cocaine dependence
Depression
Chronic back pain
Chronic back pain
Panic disorder

RP+CM (n=23)
PST (n=14)
BT+PMR (n=6)
CT+PMR (n=5)
CBT (n=34)

CM (n=24)
APST (n=14)
BT (n=4)
CT (n=5)
EX (n=29)

Effect d
.240
-.334
-1.151
-.075
-.055
-.102
-.463
-.058
.285
-.057
.091
.017 (average d)
-.736
.497
-.864
-.183 (average d)
.356
.046
-.301(average d)
-.546
-1.208
-.467
-1.324
.025
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Table B2 (continued).

Study

Disorder

More
components
group (n)

Fewer
components
group (n)

Öst et al. (1991)

Blood phobia

ATP (n=10)
ATP (n=10)

Tension only (n=10)
EX (n=10)

Paunovic & Ost (2001)
Petry et al. (2008)
Porzelius et al. (1995)
Propst et al. (1992)
Radojevic et al. (1992)

PTSD
Gambling problems
Eating disorder
Depression
Rheumatoid arthritis

CBT+EX (n=7)
MT+CBT (n=34)
OBET (n=20)
CBT-Religious (n= 10)
BT+social support (n=15)
BT+social support (n=15)

EX (n=9)
MT (n=48)
CBT (n=19)
CBT (n=10)
BT (n=14)
Social support (n=15)

Resick et al. (2008)

PTSD

CPT package (n=44)
CPT package (n=44)

CPT-C (n=36)
Written Alone (n=39)

Roehrig et al. (2006)
Rohan et al. (2007)

Body image
SAD

CA+EX (n=22)
CBT+Light Therapy(n=13)
CBT+ Light Therapy (n=13)

CA (n=28)
Light Therapy (n=14)
CBT (n=11)

CBTP (n=13)

CBT (n=11)
CBFI (n=19)
BFI (n=20)
CBT+breathing retraining(n=32) CBT (n=21)
CBT (n=13)
BT (n=13)

-.424
-.061
-.104 (average d)
-.153
-.281
-.075
-.193
-.065
-.283
-.174 (average d)
.012
-.173
-.161 (average d)
-.005
-.156
-.192
-.173 (average d)
.180
.980
-.397
-.257
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Rosen et al. (1990)
Body image
Sanders & McFarland (2000) Family behavior
Schmidt et al. (2000)
Panic Disorder
Thackwray et al. (1993)
Bulimia nervosa

Effect d

Table B2 (continued).

Study

Disorder

More
components
group (n)

Fewer
components
group (n)

MI+FB (n=67)
MI+FB (n=67)

FB (n=54)
MI (n= 59)

Walters et al. (2009)

Alcohol problems

Webster-Stratton (1994)
Williams & Falbo (1996)

Parenting effectiveness GDVM+ADVANCE (n=22)

Panic Disorder

CBT (n=11)
CBT (n=11)

GDVM (n=24)
BT (n=10)
CT (n=13)

Effect d
-.079
-.281
-.180(average d)
-.138
.148
.163
.154 (average d)

Note. Disorder: GAD = Generalized Anxiety Disorder, PTSD = Post Traumatic Stress Disorder, OCD = Obsessive-Compulsive Disorder, SAD = Seasonal Affective Disorder, HIV = Human
Immunodeficiency Virus, STD = Sexually Transmitted Disease. Component Group: CT = Cognitive Therapy; PMR = Progressive Muscle relaxation; EX = Exposure Therapy; CR = Cognitive
Restructuring; BMT = Behavioral Marital Therapy; EET = Emotional Expressiveness Training; EMDR = Eye Movement Desensitization Reprocessing; FTDR= Finger Tapping Desensitization
Restructuring; SCD = Self-Control Desensitization; AR = Applied Relaxation; CBT = Cognitive-Behavioral Therapy; IE = Imaginal Exposure; EMD-R = Eye Movement Desensitization without
Reprocessing; CMT = Child Management Training; CC = Counter Conditioning; BT = Behavior Therapy; VLCD = Very Low Calorie Diet; CRCS = Cognitive and Relaxation Coping Skills; RCS =
Relaxation Coping Skills; EMD = Eye Movement Desensitization; EFER = Eye Fixation Exposure and Reprocessing; SHR = Simplified Habit Reversal; PE = Prolonged Exposure; ERP = Exposure and
Response Prevention; FI = Family Involvement; EBMT= Enhanced Behavioral Marital Therapy; BA = Behavioral Activation; AT = Automatic Thoughts; PSST = Problem Solving Skills Training; PMT
= Parent Management Training; PPS = Parent Problem Solving; RP = Response Prevention; CM = Contingency Management; PST = Problem Solving Therapy; APST = Abbreviated Problem Solving
Therapy; ATP = Applied Tension Package; MT = Motivational Techniques; CPT = Cognitive Processing Therapy; CPT-C = Cognitive Processing Therapy without the written component; CA =
Counter Attitudinal Therapy; CBTP = Cognitive-Behavioral Therapy with Perception Training; CBFI = Cognitive-Behavioral Family Intervention; BFI = Behavioral Family Intervention; GPI = Theory
based sexual risk reduction intervention; GMET = Group Based Motivational Enhancement Therapy; MI = Motivational Interviewing; FB = Feed Back; GDVM= videotaped parent skills training
program; ADVANCE = cognitive training social learning program.
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APPENDIX C
CRITERIA FOR INCLUSION
Ahn and Wampold set the following as the criteria for inclusion in their 2001 metaanalysis:
To be included in this meta-analysis, a study had to (a) involve a
psychological treatment intended to be therapeutic for a particular disorder,
problem, or complaint and (b) contain the necessary statistics to conduct
the meta-analysis. To determine that a treatment was intended to be
therapeutic, we used the criteria developed by Wampold et al. (1997);
specifically, a treatment had to involve a therapist who had at least a
master's degree and who met face to face with the client and developed a
relationship with the client. Moreover, the treatment had to contain at least
two of the following four elements: (a) The treatment was based on an
established treatment that was cited, (b) a description of the treatment was
contained in the article, (c) a manual was used to guide administration of
the treatment, and (d) active ingredients of the treatment were identified
and cited. Finally, the study's research design had to involve a comparison
of one group with another group, and one of the following two conditions
had to be satisfied: (a) One, two, or three ingredients of the treatment were
removed, leaving a treatment that would be considered logically viable
(i.e., coherent and credible), or (b) one, two, or three ingredients that were
compatible with the whole treatment and were theoretically or empirically
hypothesized to be active were added to the treatment, providing a "super
treatment." A study was excluded when treatment A was compared with
treatment B, where B was a subset of A but both A and B were established
treatments in their own rights. (p. 252-253)

APPENDIX D
CODING SHEET FROM META-ANALYSIS DATA COLLECTION
Descriptive Information
Reference (APA style):
1. Study Number
2. Type of Publication
1 = journal
2 = book chapter
3 = other (specify)
3. Publication year:
4. Mean age of sample
a. if subgroups M of each
5. Type of Client:
1= Volunteer (like college students seeking extra credit)
2=Clinical (real client)
5b. Age=
1=Adult
2=Adolescent
3=Child
6. Sex ratio of sample (% female, % male)
a. if subgroups % of each
7. Problem Type
1 = depression
2 = anxiety (i.e., generalized anxiety disorder)
3 = grief
4 = aggression
5 = psychotic disorders (i.e. Schizophrenia, Schizoaffective Disorder, Psychotic
Mood Disorder)
6 = personality disorders/interpersonal problems (i.e., Borderline Personality
treated with DBT)
7= Substance Use
8=PTSD
9= Panic Disorder
10=Phobias
11=OCD
12=Bipolar Disorder
13=Eating Disorder
14=Somatoform and Factitious Disorders
15=Health Disorders (i.e., headaches, rheumatoid arthritis)
16=Marital Discord

17=Child behavior problems
18=Parent-training
19=enuresis
20=Mixed
21=Other
8. Type of Study design:
1= Within subjects design
2=Between subjects design
3=both
9. Treatment Location
1=residential/inpatient
2=outpatient
10. Region
1 = American
2 = European (note country/language)
3 = Other (list)
11. Treatment Intervention:
1=CBT
2=Exposure
3=IPT
4=Psychodynamic
5=Behavioral Therapy
6-Cognitive Therapy
7=DBT
8=EMDR
9=Marriage and Family Therapy
10= Applied Relaxation or PMR
11=Other
12. Measures of Pathology/Distress:
13. Sample size:
1a. total sample (Use entire sample and not treatment completers when available):
2a. Is the this just treatment completers or entire sample?
b. component sample size
c. full treatment package sample size
14. Assignment to treatments=
1= random
2= nonrandom
15. Order of treatment components:
1=Module
2=Simultaneous administration
15a= If module, are they presented in the same order?
1=yes

2=no
16. Number of sessions:
17. Length of sessions:

18.Dismantling Design:
a. More Component Group (example BT+CT-BT; EET+CR+BMT–BMT):
b. Less Component Group:
c. Component being tested:
EFFECT SIZE DATA: Feel free to copy and paste tables and then indicate on the table
the needed figure.
19. Type of data effect size is based on (provide the values including df).
Mean of more component group=
Mean of less component group=
SD=

Follow-up Data;
Provide Follow-up data at one time point, and this time point should be the follow-up
data that is closest to 6 months. If you have several time points past and it is not clear
which one is closest to the 6 month (3 month collected and 9 month collected, used the
later time point so 9 months in this example).
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